Buy pharmaceutical chemicals online | pharmaceutical chemicals manufacturers | pharmaceutical chemicals suppliers - Worldofchemicals


Elacridar analytical pure 0.999

Elacridar is a P-glycoprotein inhibitor, and has been used both in vitro and in vivo as a tool inhibitor of P-glycoprotein (Pgp) to investigate the role of transporters in the disposition of various test molecules.

Erlotinib analytical pure 0.999

Erlotinib is an EGFR inhibitor with IC50 of 2 nM, > 1000-fold more sensitive for EGFR than human c-Src or v-Abl.

GS-444217 analytical pure 0.999

ASK1-IN-1 is an apoptosis signal regulating kinase 1 (ASK1) inhibitor.

GSK1904529A analytical pure 98%

GSK1904529A is a selective inhibitor of IGF-1R and IR with IC50 of 27 nM and 25 nM, being > 100-fold selective for IGF-1R/InsR than Akt1/2, Aurora A/B,B-Raf, CDK2, EGFR etc.

GSK690693 analytical pure 0.994

GSK690693 is a pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 2 nM/13 nM/9 nM, also sensitive to the AGC kinase family: PKA, PrkX and PKC isozymes.

Gefitinib analytical pure 0.999

Gefitinibis an EGFR inhibitor for Tyr1173, Tyr992, Tyr1173 and Tyr992 in the NR6wtEGFR and NR6W cells with IC50 of 37 nM, 37nM, 26 nM and 57 nM, respectively, and interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells.

I-BET-151 analytical pure 0.982

I-BET-151 is a selective BET inhibitor for BRD2, BRD3 and BRD4 with IC50 of 0.5 μM, 0.25 μM, and 0.79 μM in cell-free assays, respectively.

I-BET-762 analytical pure 0.993

I-BET 762 is an inhibitor for BET proteins with IC50 of ~35 nM.

Ibrutinib analytical pure 0.999

Ibrutinib is a potent Btk inhibitor with IC50 value of 0.5nM, modestly potent to Blk (IC50=0.5nM), Bmx (IC50=0.8nM), CSK (IC50=2.3nM), FGR (IC50=2.3nM), BRK (IC50=3.3nM), HCK (IC50=3.7nM).

Icatibant analytical pure 0.985

Icatibant is a selective and specific antagonist of bradykinin B2 receptor with IC50 and Ki of 1.07 nM and 0.798 nM respectively.

Suppliers uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X